Mangrove Partners’s PepperLime Health Acquisition Corporation Unit PEPLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-400,000
Closed -$4.07M 692
2021
Q4
$4.07M Buy
+400,000
New +$4M 0.24% 106

Other funds holding PEPLU

Mangrove Partners's PEPLU Position: Q1 2022 in Review

Mangrove Partners sold out of PepperLime Health Acquisition Corporation Unit (PEPLU) in Q1 2022, closing a stake of 400,000 shares — an estimated $4.07M sold.

Mangrove Partners first reported a position in PEPLU in Q4 2021 and held it in 1 quarter. The position peaked at $4.07M in Q4 2021. 15 funds tracked by Wall St. Rank hold PEPLU as of Q1 2022.

  • Mangrove Partners reported no remaining PepperLime Health Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
  • Mangrove Partners sold 400,000 PepperLime Health Acquisition Corporation Unit shares in Q1 2022, an estimated $4.07M.
  • Mangrove Partners first reported a position in PepperLime Health Acquisition Corporation Unit in Q4 2021 and held it in 1 quarter.
  • Mangrove Partners's PepperLime Health Acquisition Corporation Unit position peaked at $4.07M in Q4 2021.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Unit as of Q1 2022.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.